Evidence map›Paper›PMID 34869761›Full record

ArticleBioMed research international2021

Development of a 15-Gene Signature Model as a Prognostic Tool in Sex Hormone-Dependent Cancers.

Zhi Xia, Jian Xiao, Aibin Liu, Qiong Chen

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zhi XiaDepartment of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China.ORCID https://orcid.org/0000-0002-1522-8089
Jian XiaoDepartment of Gerontology and Respiratory Diseases Xiangya Hospital Central South University, Changsha, Hunan 410008, China.ORCID https://orcid.org/0000-0003-2761-1779
Aibin LiuDepartment of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China.ORCID https://orcid.org/0000-0003-1600-8288
Qiong ChenDepartment of Geriatrics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China.ORCID https://orcid.org/0000-0002-2534-8834
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sex hormone dependence is associated with tumor progression and prognosis. Here, we explored the molecular basis of luminal A-like phenotype in sex hormone-dependent cancers. RNA-sequencing data from 8 cancer types were obtained from The Cancer Genome Atlas (TCGA). We investigated the enrichment function of differentially expressed genes (DEGs) in luminal A breast cancer (BRCA). Weighted coexpression network analysis (WGCNA) was used to identify gene modules associated with the luminal A-like phenotype, and we calculated the module's preservation in 8 cancer types. Module hub genes screened using least absolute shrinkage and selection operator (LASSO) were used to construct a gene signature model for the luminal A-like phenotype, and we assessed the model's relationship with prognosis, enriched pathways, and immune infiltration using bioinformatics approaches. Compared to other BRCA subtypes, the enrichment functions of upregulated genes in luminal A BRCA were related to hormone biological processes and receptor activity, and the downregulated genes were associated with the cell cycle and nuclear division. A gene module significantly associated with luminal A BRCA was shared by uterine corpus endometrial carcinoma (UCEC), leading to a similar phenotype. Fifteen hub genes were used to construct a gene signature model for the assessment of the luminal A-like phenotype, and the corrected

Indexed as

Breast NeoplasmsCD4-Positive T-LymphocytesCell CycleComputational BiologyDNA ReplicationDown-RegulationFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksGonadal Steroid HormonesHumansPhenotypePrognosisUp-RegulationGonadal Steroid Hormones

Identifiers

PMID34869761
PMCPMC8635877
OpenAlexW3216066364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.